Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Mesothelioma × Radiosurgery × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 30 Lung Neoplasms 18 Brain Neoplasms 18 Prostatic Neoplasms 17 Neoplasm Metastasis 17 Pancreatic Neoplasms 16 Carcinoma, Hepatocellular 15 Melanoma 14 Breast Neoplasms 10 Carcinoma, Renal Cell 8 Squamous Cell Carcinoma of Head and Neck 7 Neoplasms 6 Glioblastoma 6 Small Cell Lung Carcinoma 5 Sarcoma 5 Liver Neoplasms 4 Recurrence 3 Kidney Neoplasms 3 Head and Neck Neoplasms 3 Gliosarcoma 3 Glioma 3 Colonic Neoplasms 3 Adenocarcinoma of Lung 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Sarcoma, Ewing 2 Salivary Gland Neoplasms 2 Rectal Neoplasms 2 Radiation Injuries 2 Pain 2

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04166734 2026-02-04

MESO-PRIME

Royal Marsden NHS Foundation Trust

Phase 1 Terminated

5 enrolled 13 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡